New CAR-T therapy shows promise for Hard-to-Treat myeloma
Disease control
Recruiting now
This early-stage trial tests a new treatment for adults with multiple myeloma that has come back or not responded to other therapies. The treatment uses immune cells from donated cord blood that are specially designed to target and kill myeloma cells. The main goals are to check …
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated May 07, 2026 18:40 UTC